Press Release

lncRNA that suppresses melanoma tumors has been identified

lncrna

A promising route to develop new treatments for skin cancer has been identified by University of Bath scientists, who have found a molecule that suppresses melanoma tumour growth. Although the research is at an early stage, the team hope that their work could help develop new ways to combat melanoma and potentially other cancers too. The team from the University ...

Read More »

Abivax Treats First Patient in Phase 2a Rheumatoid Arthritis Clinical Trial of ABX464

lncRNA

Abivax, a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, announced today that the first patient was dosed in study ABX464-301, a phase 2a clinical trial of ABX464 to treat patients with moderate to severe active rheumatoid arthritis (RA). The trial has been fully approved in four countries (France, Poland, ...

Read More »